Richard David Lee, MD
Family Practice · Portola Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office at (650) 280-0110 to ask if they take your plan before you enroll.
California Medical Board record
Licence G72042 · Current
Licensed to practise in California · since 1991 · expires 2027-03-31 · Michigan State University College of Human Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,027
Medicare paid this office $30,027 for 114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 75 | $14,865 | $70 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,509 | $148 |
| Return visit (30+ min) | 26 | $4,266 | $104 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $289 | $10 |
Who their Medicare patients are
114 Original Medicare patients in 2024. Average age 74 · Women 51% · Health risk score 0.67. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 39% · Coronary heart disease 16% · Atrial fibrillation 10%.
The office billed $49,985, Medicare allowed $40,214 and paid $30,027; for 439 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 114 | 439 | 74 | 0.67 | $49,985 | $30,027 |
| 2023 | 107 | 456 | 74 | 0.66 | $52,490 | $31,405 |
| 2022 | 121 | 486 | 74 | 0.76 | $58,575 | $32,224 |
| 2021 | 103 | 468 | 73 | 0.74 | $55,502 | $32,725 |
| 2020 | 83 | 375 | 72 | 0.82 | $43,614 | $21,622 |
| 2019 | 81 | 353 | 71 | 0.82 | $44,561 | $23,170 |
| 2018 | 78 | 364 | 72 | 1.00 | $42,748 | $22,141 |
| 2017 | 79 | 345 | 73 | 0.89 | $42,503 | $20,542 |
| 2016 | 85 | 359 | 73 | 0.79 | $42,494 | $23,106 |
| 2015 | 77 | 339 | 73 | 0.75 | $43,848 | $22,609 |
| 2014 | 90 | 390 | 73 | 0.75 | $47,316 | $24,359 |
| 2013 | 79 | 352 | 74 | 0.73 | $45,813 | $23,985 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 75 | $16,466 | $70 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $5,956 | $145 |
| Return visit (30+ min) | 28 | $4,123 | $101 |
| Short return visit | 15 | $1,241 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 44 | $488 | $11 |
2022: 5 services
| Short return visit (20+ min) | 71 | $13,830 | $66 |
| Return visit (30+ min) | 46 | $6,683 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,410 | $146 |
| Short return visit | 17 | $919 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 43 | $446 | $9 |
2021: 7 services
| Short return visit (20+ min) | 62 | $12,368 | $69 |
| Return visit (30+ min) | 35 | $7,200 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,301 | $151 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $2,871 | $191 |
| Short return visit | 20 | $896 | $43 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $894 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $538 | $11 |
2020: 6 services
| Return visit (30+ min) | 41 | $8,216 | $83 |
| Short return visit (20+ min) | 44 | $5,748 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,222 | $134 |
| Administration of influenza virus vaccine | 14 | $334 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $310 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $258 | $10 |
2019: 4 services
| Return visit (30+ min) | 50 | $9,888 | $85 |
| Short return visit (20+ min) | 46 | $5,951 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,435 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $377 | $11 |
2018: 4 services
| Return visit (30+ min) | 43 | $7,912 | $83 |
| Short return visit (20+ min) | 46 | $5,199 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,626 | $129 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35 | $350 | $10 |
2017: 4 services
| Short return visit (20+ min) | 51 | $7,504 | $52 |
| Return visit (30+ min) | 40 | $6,573 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,433 | $123 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $204 | $15 |
2016: 3 services
| Short return visit (20+ min) | 57 | $8,450 | $53 |
| Return visit (30+ min) | 41 | $7,094 | $85 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,716 | $128 |
2015: 3 services
| Return visit (30+ min) | 56 | $10,055 | $81 |
| Short return visit (20+ min) | 50 | $6,344 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $2,994 | $130 |
2014: 3 services
| Short return visit (20+ min) | 54 | $8,105 | $56 |
| Return visit (30+ min) | 45 | $7,836 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,206 | $123 |
2013: 4 services
| Return visit (30+ min) | 49 | $10,699 | $84 |
| Short return visit (20+ min) | 39 | $5,406 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,299 | $127 |
| Injection of drug or substance under skin or into muscle | 12 | $1,158 | $20 |
Drugs they prescribed that Part D paid
$114,132
Pharmacies billed $114,132 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (35 of 1,259) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,054 generic and 205 brand-name prescriptions · $114,132 in drug cost · 102 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 21 | $14,595 | $695 |
| Mounjaro | 12 | $12,313 | $1,026 |
| Januvia | 16 | $11,547 | $722 |
| Linzess | 13 | $6,722 | $517 |
| Testosterone | 15 | $5,294 | $353 |
See all 38 drugs
| Eliquis | 21 | $14,595 | $695 |
| Mounjaro | 12 | $12,313 | $1,026 |
| Januvia | 16 | $11,547 | $722 |
| Linzess | 13 | $6,722 | $517 |
| Testosterone | 15 | $5,294 | $353 |
| Synthroid | 35 | $2,777 | $79 |
| Liothyronine | 45 | $2,280 | $51 |
| Estradiol | 13 | $1,576 | $121 |
| Levothyroxine | 96 | $1,316 | $14 |
| Estradiol (Twice Weekly) | 12 | $784 | $65 |
| Celecoxib | 22 | $688 | $31 |
| Hydrocodone-Acetaminophen | 21 | $661 | $31 |
| Ondansetron Odt | 14 | $599 | $43 |
| Valacyclovir | 18 | $572 | $32 |
| Lorazepam | 44 | $525 | $12 |
| Gabapentin | 26 | $523 | $20 |
| Tamsulosin | 33 | $506 | $15 |
| Duloxetine | 12 | $505 | $42 |
| Losartan | 65 | $493 | $8 |
| Hydrocortisone | 16 | $434 | $27 |
| Dextroamphetamine-Amphetamine | 15 | $386 | $26 |
| Clonazepam | 19 | $300 | $16 |
| Azithromycin | 38 | $231 | $6 |
| Mupirocin | 11 | $219 | $20 |
| Rosuvastatin | 17 | $209 | $12 |
| Trazodone | 15 | $180 | $12 |
| Potassium Chloride | 16 | $158 | $10 |
| Amlodipine Besylate | 22 | $137 | $6 |
| Atorvastatin | 16 | $135 | $8 |
| Levofloxacin | 12 | $88 | $7 |
| Metformin | 26 | $78 | $3 |
| Lisinopril | 12 | $70 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $68 | $6 |
| Hydrochlorothiazide | 15 | $67 | $4 |
| Sumatriptan | 15 | $66 | $4 |
| Allopurinol | 13 | $47 | $4 |
| Furosemide | 11 | $26 | $2 |
| Metoprolol | 12 | $17 | $1 |
Year by year
| 2024 | 1,259 | 100 | 3% (35) | 16% | $114,132 |
| 2023 | 1,267 | 97 | 5% (65) | 15% | $139,738 |
| 2022 | 1,190 | 103 | 6% (72) | 16% | $108,838 |
| 2021 | 1,182 | 89 | 4% (42) | 15% | $111,018 |
| 2020 | 1,196 | 85 | 5% (58) | 18% | $94,284 |
| 2019 | 1,117 | 82 | 5% (59) | 19% | $91,487 |
| 2018 | 1,111 | 79 | 5% (57) | None | $86,869 |
| 2017 | 1,179 | 82 | 4% (51) | None | $82,974 |
| 2016 | 1,233 | 77 | 4% (46) | None | $85,971 |
| 2015 | 1,227 | 75 | 5% (61) | None | $92,782 |
| 2014 | 1,079 | 89 | 3% (31) | None | $80,894 |
| 2013 | 904 | 89 | 3% (25) | None | $71,906 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Mounjaro | 13 | $14,187 | $1,091 |
| Eliquis | 11 | $10,976 | $998 |
| Myrbetriq | 20 | $10,208 | $510 |
| Januvia | 11 | $9,870 | $897 |
| Estradiol (Twice Weekly) | 18 | $1,979 | $110 |
| Levothyroxine | 102 | $1,932 | $19 |
| Liothyronine | 29 | $1,735 | $60 |
| Synthroid | 15 | $1,592 | $106 |
| Hydrocodone-Acetaminophen | 31 | $1,255 | $40 |
| Valacyclovir | 19 | $1,008 | $53 |
| Losartan | 53 | $845 | $16 |
| Celecoxib | 22 | $811 | $37 |
| Bupropion Xl | 14 | $709 | $51 |
| Gabapentin | 32 | $688 | $22 |
| Pregabalin | 12 | $677 | $56 |
| Lorazepam | 37 | $568 | $15 |
| Amlodipine Besylate | 21 | $486 | $23 |
| Azithromycin | 54 | $445 | $8 |
| Tamsulosin | 19 | $432 | $23 |
| Trazodone | 22 | $373 | $17 |
| Olmesartan Medoxomil | 13 | $282 | $22 |
| Atorvastatin | 22 | $276 | $13 |
| Metformin | 20 | $263 | $13 |
| Clonazepam | 15 | $250 | $17 |
| Escitalopram | 11 | $243 | $22 |
| Rosuvastatin | 14 | $167 | $12 |
| Hydrochlorothiazide | 15 | $158 | $11 |
| Simvastatin | 14 | $136 | $10 |
| Metoprolol | 11 | $135 | $12 |
| Mupirocin | 14 | $81 | $6 |
| Furosemide | 15 | $77 | $5 |
| Tramadol | 20 | $74 | $4 |
2022: 36 drugs
| Jardiance | 14 | $12,198 | $871 |
| Lumigan | 11 | $6,724 | $611 |
| Myrbetriq | 13 | $6,638 | $511 |
| Liothyronine | 32 | $2,900 | $91 |
| Levothyroxine | 116 | $2,836 | $24 |
| Synthroid | 20 | $2,093 | $105 |
| Sodium Chloride | 14 | $1,889 | $135 |
| Valacyclovir | 16 | $1,728 | $108 |
| Estradiol (Twice Weekly) | 14 | $1,293 | $92 |
| Celecoxib | 23 | $1,184 | $51 |
| Eszopiclone | 14 | $928 | $66 |
| Hydrocodone-Acetaminophen | 39 | $812 | $21 |
| Dextroamphetamine-Amphet Er | 13 | $707 | $54 |
| Escitalopram | 11 | $613 | $56 |
| Tamsulosin | 35 | $605 | $17 |
| Methylphenidate | 13 | $557 | $43 |
| Clonazepam | 24 | $542 | $23 |
| Losartan | 57 | $486 | $9 |
| Metoprolol | 14 | $456 | $33 |
| Zolpidem | 13 | $408 | $31 |
| Progesterone | 12 | $400 | $33 |
| Gabapentin | 19 | $383 | $20 |
| Azithromycin | 46 | $312 | $7 |
| Cyclobenzaprine | 15 | $297 | $20 |
| Ondansetron Odt | 15 | $279 | $19 |
| Lorazepam | 31 | $270 | $9 |
| Amitriptyline | 11 | $265 | $24 |
| Atorvastatin | 18 | $184 | $10 |
| Trazodone | 11 | $183 | $17 |
| Tramadol | 22 | $145 | $7 |
| Levofloxacin | 14 | $125 | $9 |
| Bupropion Hcl Sr | 13 | $116 | $9 |
| Finasteride | 13 | $114 | $9 |
| Amlodipine Besylate | 20 | $107 | $5 |
| Hydrochlorothiazide | 22 | $78 | $4 |
| Simvastatin | 13 | $54 | $4 |
2021: 35 drugs
| Eliquis | 17 | $8,684 | $511 |
| Lovaza | 18 | $6,025 | $335 |
| Liothyronine | 31 | $3,409 | $110 |
| Levothyroxine | 107 | $2,803 | $26 |
| Eszopiclone | 32 | $2,448 | $77 |
| Synthroid | 28 | $2,132 | $76 |
| Estradiol (Twice Weekly) | 15 | $1,883 | $126 |
| Clonazepam | 37 | $1,715 | $46 |
| Celecoxib | 24 | $1,425 | $59 |
| Sodium Chloride | 13 | $1,386 | $107 |
| Valacyclovir | 16 | $1,272 | $79 |
| Tamsulosin | 39 | $659 | $17 |
| Escitalopram | 12 | $653 | $54 |
| Losartan | 46 | $524 | $11 |
| Finasteride | 13 | $385 | $30 |
| Progesterone | 11 | $365 | $33 |
| Lorazepam | 28 | $364 | $13 |
| Gabapentin | 21 | $351 | $17 |
| Hydrocodone-Acetaminophen | 12 | $310 | $26 |
| Levofloxacin | 15 | $292 | $19 |
| Temazepam | 12 | $254 | $21 |
| Acetaminophen-Codeine | 14 | $232 | $17 |
| Atorvastatin | 14 | $172 | $12 |
| Azithromycin | 23 | $159 | $7 |
| Metformin | 14 | $154 | $11 |
| Trazodone | 15 | $146 | $10 |
| Lisinopril | 18 | $128 | $7 |
| Zolpidem | 13 | $120 | $9 |
| Simvastatin | 16 | $95 | $6 |
| Bupropion Hcl Sr | 12 | $95 | $8 |
| Hydrochlorothiazide | 15 | $87 | $6 |
| Chlorhexidine Gluconate | 13 | $80 | $6 |
| Amlodipine Besylate | 33 | $62 | $2 |
| Cyclobenzaprine | 12 | $62 | $5 |
| Tramadol | 12 | $49 | $4 |
2020: 30 drugs
| Testosterone | 17 | $10,182 | $599 |
| Liothyronine | 34 | $3,380 | $99 |
| Levothyroxine | 112 | $2,642 | $24 |
| Synthroid | 29 | $2,284 | $79 |
| Valacyclovir | 11 | $1,746 | $159 |
| Hydroxychloroquine Sulfate | 35 | $1,628 | $47 |
| Sodium Chloride | 14 | $1,394 | $100 |
| Eszopiclone | 23 | $1,043 | $45 |
| Metoprolol | 12 | $813 | $68 |
| Clonazepam | 29 | $688 | $24 |
| Lorazepam | 31 | $600 | $19 |
| Losartan | 46 | $565 | $12 |
| Escitalopram | 13 | $538 | $41 |
| Gabapentin | 17 | $478 | $28 |
| Pantoprazole | 21 | $458 | $22 |
| Hydrocodone-Acetaminophen | 12 | $449 | $37 |
| Fluconazole | 12 | $413 | $34 |
| Tamsulosin | 34 | $317 | $9 |
| Azithromycin | 39 | $275 | $7 |
| Acetaminophen-Codeine | 20 | $269 | $13 |
| Zolpidem | 25 | $242 | $10 |
| Gentamicin Sulfate | 14 | $213 | $15 |
| Sumatriptan | 13 | $212 | $16 |
| Metformin | 21 | $196 | $9 |
| Temazepam | 14 | $194 | $14 |
| Hydrochlorothiazide | 17 | $127 | $7 |
| Carisoprodol | 14 | $63 | $4 |
| Simvastatin | 18 | $61 | $3 |
| Amitriptyline | 11 | $59 | $5 |
| Amlodipine Besylate | 25 | $53 | $2 |
2019: 34 drugs
| Testosterone | 26 | $14,743 | $567 |
| Liothyronine | 31 | $2,617 | $84 |
| Butalbital Compound-Codeine | 22 | $2,552 | $116 |
| Levothyroxine | 97 | $2,160 | $22 |
| Synthroid | 26 | $1,548 | $60 |
| Zolpidem | 22 | $1,468 | $67 |
| Gabapentin | 16 | $1,059 | $66 |
| Eszopiclone | 24 | $977 | $41 |
| Armour Thyroid | 11 | $893 | $81 |
| Clonazepam | 26 | $711 | $27 |
| Valacyclovir | 17 | $697 | $41 |
| Hydrocodone-Acetaminophen | 13 | $568 | $44 |
| Celecoxib | 16 | $474 | $30 |
| Lorazepam | 25 | $377 | $15 |
| Pantoprazole | 25 | $366 | $15 |
| Losartan | 33 | $329 | $10 |
| Montelukast | 17 | $281 | $17 |
| Levofloxacin | 17 | $279 | $16 |
| Pravastatin | 13 | $260 | $20 |
| Tamsulosin | 29 | $223 | $8 |
| Azithromycin | 27 | $219 | $8 |
| Temazepam | 13 | $202 | $16 |
| Atorvastatin | 14 | $199 | $14 |
| Simvastatin | 17 | $189 | $11 |
| Metformin | 16 | $172 | $11 |
| Mupirocin | 15 | $149 | $10 |
| Sumatriptan | 11 | $113 | $10 |
| Hydrochlorothiazide | 14 | $108 | $8 |
| Promethazine | 15 | $91 | $6 |
| Carisoprodol | 16 | $76 | $5 |
| Lisinopril | 14 | $66 | $5 |
| Amitriptyline | 12 | $49 | $4 |
| Tramadol | 11 | $45 | $4 |
| Amlodipine Besylate | 19 | $21 | $1 |
2018: 31 drugs
| Alvesco | 12 | $3,786 | $315 |
| Levothyroxine | 107 | $2,070 | $19 |
| Synthroid | 34 | $1,992 | $59 |
| Liothyronine | 28 | $1,704 | $61 |
| Duloxetine | 16 | $1,286 | $80 |
| Zolpidem | 24 | $1,063 | $44 |
| Eszopiclone | 24 | $1,025 | $43 |
| Modafinil | 11 | $1,004 | $91 |
| Levofloxacin | 12 | $869 | $72 |
| Sodium Chloride | 15 | $777 | $52 |
| Bethanechol Chloride | 12 | $648 | $54 |
| Escitalopram | 15 | $553 | $37 |
| Pravastatin | 15 | $506 | $34 |
| Clonazepam | 22 | $464 | $21 |
| Montelukast | 27 | $411 | $15 |
| Gabapentin | 16 | $379 | $24 |
| Pantoprazole | 19 | $306 | $16 |
| Tamsulosin | 22 | $295 | $13 |
| Losartan | 27 | $292 | $11 |
| Lorazepam | 21 | $288 | $14 |
| Metformin | 31 | $271 | $9 |
| Atorvastatin | 13 | $219 | $17 |
| Hydrochlorothiazide | 16 | $171 | $11 |
| Sumatriptan | 13 | $146 | $11 |
| Mupirocin | 18 | $140 | $8 |
| Simvastatin | 22 | $131 | $6 |
| Azithromycin | 18 | $120 | $7 |
| Promethazine | 13 | $115 | $9 |
| Tramadol | 23 | $103 | $4 |
| Carisoprodol | 15 | $81 | $5 |
| Lisinopril | 12 | $35 | $3 |
2017: 36 drugs
| Alvesco | 11 | $5,003 | $455 |
| Celecoxib | 13 | $2,433 | $187 |
| Duloxetine | 48 | $2,164 | $45 |
| Levothyroxine | 90 | $1,882 | $21 |
| Synthroid | 39 | $1,847 | $47 |
| Liothyronine | 46 | $1,652 | $36 |
| Butalbital-Acetaminophen-Caffe | 29 | $1,105 | $38 |
| Bethanechol Chloride | 15 | $798 | $53 |
| Butalb-Caff-Acetaminoph-Codein | 12 | $750 | $62 |
| Fludrocortisone Acetate | 15 | $643 | $43 |
| Zolpidem | 16 | $554 | $35 |
| Tamsulosin | 24 | $525 | $22 |
| Clonazepam | 29 | $513 | $18 |
| Pravastatin | 21 | $393 | $19 |
| Bupropion Hcl Sr | 14 | $378 | $27 |
| Levofloxacin | 14 | $325 | $23 |
| Azithromycin | 41 | $308 | $8 |
| Escitalopram | 18 | $305 | $17 |
| Metformin | 37 | $292 | $8 |
| Pantoprazole | 20 | $264 | $13 |
| Gabapentin | 21 | $250 | $12 |
| Montelukast | 17 | $246 | $14 |
| Amlodipine Besylate | 16 | $204 | $13 |
| Atorvastatin | 13 | $200 | $15 |
| Promethazine | 14 | $158 | $11 |
| Carisoprodol | 19 | $149 | $8 |
| Simvastatin | 16 | $140 | $9 |
| Losartan | 17 | $136 | $8 |
| Lorazepam | 16 | $131 | $8 |
| Sumatriptan | 12 | $128 | $11 |
| Tramadol | 16 | $113 | $7 |
| Allopurinol | 15 | $109 | $7 |
| Mupirocin | 12 | $95 | $8 |
| Sertraline | 15 | $91 | $6 |
| Hydrochlorothiazide | 14 | $73 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $70 | $6 |
2016: 33 drugs
| Alvesco | 12 | $5,369 | $447 |
| Synthroid | 44 | $2,909 | $66 |
| Liothyronine | 71 | $2,782 | $39 |
| Levothyroxine | 112 | $2,227 | $20 |
| Celecoxib | 16 | $2,198 | $137 |
| Duloxetine | 18 | $1,394 | $77 |
| Butalbital-Acetaminophen-Caffe | 28 | $1,218 | $44 |
| Azelastine | 12 | $1,030 | $86 |
| Hydrocortisone | 20 | $776 | $39 |
| Clonazepam | 25 | $662 | $26 |
| Tamsulosin | 35 | $654 | $19 |
| Fludrocortisone Acetate | 15 | $644 | $43 |
| Pravastatin | 24 | $575 | $24 |
| Gabapentin | 26 | $573 | $22 |
| Metformin | 61 | $484 | $8 |
| Eszopiclone | 11 | $474 | $43 |
| Escitalopram | 31 | $462 | $15 |
| Montelukast | 32 | $423 | $13 |
| Azithromycin | 36 | $257 | $7 |
| Levofloxacin | 13 | $215 | $17 |
| Bupropion Hcl Sr | 13 | $181 | $14 |
| Diazepam | 16 | $169 | $11 |
| Mupirocin | 12 | $153 | $13 |
| Alprazolam | 16 | $139 | $9 |
| Losartan | 12 | $138 | $12 |
| Lorazepam | 18 | $138 | $8 |
| Simvastatin | 15 | $134 | $9 |
| Sertraline | 20 | $112 | $6 |
| Hydrochlorothiazide | 15 | $110 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $105 | $9 |
| Carisoprodol | 13 | $91 | $7 |
| Allopurinol | 16 | $73 | $5 |
| Tramadol | 13 | $68 | $5 |
2015: 34 drugs
| Testim | 14 | $12,643 | $903 |
| Alvesco | 13 | $5,492 | $422 |
| Celecoxib | 23 | $2,939 | $128 |
| Levothyroxine | 123 | $2,298 | $19 |
| Duloxetine | 16 | $2,007 | $125 |
| Liothyronine | 63 | $1,741 | $28 |
| Synthroid | 34 | $1,547 | $46 |
| Hydrocodone-Acetaminophen | 12 | $1,273 | $106 |
| Eszopiclone | 11 | $1,227 | $112 |
| Levofloxacin | 20 | $662 | $33 |
| Pravastatin | 24 | $571 | $24 |
| Escitalopram | 31 | $530 | $17 |
| Butalbital-Acetaminophen-Caffe | 13 | $517 | $40 |
| Montelukast | 40 | $509 | $13 |
| Hydrocortisone | 19 | $423 | $22 |
| Fludrocortisone Acetate | 12 | $412 | $34 |
| Gabapentin | 20 | $405 | $20 |
| Oxycodone | 14 | $403 | $29 |
| Atorvastatin | 15 | $373 | $25 |
| Omeprazole | 13 | $287 | $22 |
| Losartan | 28 | $276 | $10 |
| Clonazepam | 19 | $252 | $13 |
| Metformin | 43 | $217 | $5 |
| Mupirocin | 18 | $214 | $12 |
| Lorazepam | 26 | $208 | $8 |
| Azithromycin | 21 | $159 | $8 |
| Tramadol | 25 | $117 | $5 |
| Acyclovir | 11 | $110 | $10 |
| Hydrochlorothiazide | 13 | $108 | $8 |
| Allopurinol | 14 | $103 | $7 |
| Sertraline | 16 | $97 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $88 | $7 |
| Meloxicam | 11 | $80 | $7 |
| Simvastatin | 16 | $80 | $5 |
2014: 30 drugs
| Celebrex | 18 | $4,193 | $233 |
| Duloxetine | 15 | $2,809 | $187 |
| Coreg Cr | 12 | $2,073 | $173 |
| Levothyroxine | 122 | $1,854 | $15 |
| Pataday | 11 | $1,548 | $141 |
| Liothyronine | 36 | $1,221 | $34 |
| Hydrocodone-Acetaminophen | 15 | $1,016 | $68 |
| Montelukast | 33 | $830 | $25 |
| Methylphenidate | 17 | $732 | $43 |
| Escitalopram | 31 | $579 | $19 |
| Losartan | 37 | $544 | $15 |
| Synthroid | 13 | $519 | $40 |
| Atorvastatin | 15 | $508 | $34 |
| Pravastatin | 22 | $468 | $21 |
| Clonazepam | 27 | $453 | $17 |
| Omeprazole | 24 | $440 | $18 |
| Promethazine | 11 | $310 | $28 |
| Lorazepam | 21 | $297 | $14 |
| Diphenoxylate-Atropine | 13 | $274 | $21 |
| Citalopram Hbr | 14 | $250 | $18 |
| Diazepam | 33 | $243 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $129 | $8 |
| Mupirocin | 13 | $123 | $9 |
| Azithromycin | 15 | $122 | $8 |
| Gabapentin | 14 | $119 | $8 |
| Metformin | 18 | $95 | $5 |
| Simvastatin | 13 | $91 | $7 |
| Enalapril-Hydrochlorothiazide | 11 | $90 | $8 |
| Donepezil | 11 | $88 | $8 |
| Alprazolam | 11 | $61 | $6 |
2013: 28 drugs
| Celebrex | 27 | $5,185 | $192 |
| Testim | 12 | $4,412 | $368 |
| Axiron | 11 | $3,957 | $360 |
| Cymbalta | 14 | $2,949 | $211 |
| Namenda | 11 | $2,892 | $263 |
| Liothyronine | 38 | $1,985 | $52 |
| Montelukast | 27 | $1,762 | $65 |
| Pataday | 11 | $1,405 | $128 |
| Omeprazole | 23 | $1,061 | $46 |
| Hydrocortisone | 16 | $1,053 | $66 |
| Escitalopram | 24 | $842 | $35 |
| Levothyroxine | 59 | $809 | $14 |
| Losartan | 48 | $775 | $16 |
| Nitrofurantoin | 12 | $658 | $55 |
| Pravastatin | 27 | $375 | $14 |
| Latanoprost | 12 | $369 | $31 |
| Tamsulosin | 17 | $356 | $21 |
| Gabapentin | 15 | $312 | $21 |
| Metformin | 13 | $261 | $20 |
| Simvastatin | 18 | $170 | $9 |
| Azithromycin | 14 | $140 | $10 |
| Citalopram Hbr | 12 | $139 | $12 |
| Zolpidem | 13 | $130 | $10 |
| Amlodipine Besylate | 13 | $114 | $9 |
| Hydrocodone-Acetaminophen | 13 | $103 | $8 |
| Hydrochlorothiazide | 18 | $98 | $5 |
| Diazepam | 14 | $89 | $6 |
| Enalapril-Hydrochlorothiazide | 12 | $88 | $7 |
Money from drug and device companies
$957 in 2025
| 2025 | 11 | 37 | None | $957 |
| 2024 | 9 | 38 | None | $866 |
| 2023 | 7 | 33 | None | $631 |
| 2022 | 5 | 26 | $1,200 | $2,235 |
| 2021 | 6 | 30 | None | $543 |
| 2020 | 6 | 9 | None | $179 |
| 2019 | 5 | 12 | None | $243 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Nurtec Odt | $342 | 12 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $196 | 8 payments
|
| Lilly USA | Mounjaro | $114 | 4 payments
|
| Abbvie | Qulipta | $90 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $58 | 2 payments
|
| Antares Pharma | Xyosted | $49 | 2 payments
|
See all 37 published payments
| Exact Sciences | Meals · 2025-12-16 | None | $32 |
| Pfizer | Meals · 2025-12-03 | Nurtec Odt | $23 |
| Acella Pharmaceuticals | Meals · 2025-11-18 | NP Thyroid 60 | $24 |
| Pfizer | Meals · 2025-11-04 | Nurtec Odt | $20 |
| Exact Sciences | Meals · 2025-10-30 | The Cologuard Plus Collection Kit | $21 |
| Lilly USA | Meals · 2025-10-08 | Mounjaro | $29 |
| Pfizer | Meals · 2025-09-30 | Nurtec Odt | $19 |
| Exact Sciences | Meals · 2025-09-10 | The Cologuard Plus Collection Kit | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-08 | Kerendia | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-20 | Caplyta | $28 |
| Pfizer | Meals · 2025-08-11 | Nurtec Odt | $18 |
| Pfizer | Meals · 2025-08-06 | Eliquis | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-28 | Caplyta | $30 |
| Lilly USA | Meals · 2025-07-22 | Zepbound | $27 |
| Novo Nordisk | Meals · 2025-07-14 | Wegovy | $22 |
| Exact Sciences | Meals · 2025-07-08 | The Cologuard Plus Collection Kit | $25 |
| Eisai | Meals · 2025-06-23 | Leqembi | $19 |
| Pfizer | Meals · 2025-06-16 | Eliquis | $27 |
| Pfizer | Meals · 2025-06-12 | Zavzpret | $108 |
| Pfizer | Meals · 2025-06-09 | Nurtec Odt | $19 |
| Pfizer | Meals · 2025-06-05 | Nurtec Odt | $19 |
| Idorsia Pharmaceuticals US | Meals · 2025-05-28 | Quviviq | $22 |
| Exact Sciences | Meals · 2025-05-27 | The Cologuard Plus Collection Kit | $28 |
| Pfizer | Meals · 2025-04-29 | Eliquis | $20 |
| Lilly USA | Meals · 2025-04-23 | Mounjaro | $29 |
| Antares Pharma | Meals · 2025-04-16 | Xyosted | $23 |
| Exact Sciences | Meals · 2025-04-15 | The Cologuard Plus Collection Kit | $26 |
| Lilly USA | Meals · 2025-04-03 | Mounjaro | $29 |
| Exact Sciences | Meals · 2025-03-26 | Cologuard Collection Kit | $24 |
| Abbvie | Meals · 2025-03-19 | Qulipta | $33 |
| Abbvie | Meals · 2025-02-25 | Qulipta | $18 |
| Pfizer | Meals · 2025-02-25 | Nurtec Odt | $17 |
| Exact Sciences | Meals · 2025-02-25 | Cologuard Collection Kit | $19 |
| Abbvie | Meals · 2025-02-19 | Ubrelvy | $24 |
| Antares Pharma | Meals · 2025-02-04 | Xyosted | $25 |
| Pfizer | Meals · 2025-01-23 | Nurtec Odt | $24 |
| Abbvie | Meals · 2025-01-06 | Qulipta | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $866
| Abbvie | Qulipta | $348 | 18 payments
|
| Pfizer | Nurtec Odt | $236 | 11 payments
|
| Carlsmed | Aprevo | $108 | 1 payment
|
| Amgen | Otezla | $47 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $45 | 2 payments
|
| Acella Pharmaceuticals | NP Thyroid 60 | $24 | 1 payment
|
| Lilly USA | Mounjaro | $22 | 1 payment
|
| Antares Pharma | Xyosted | $19 | 1 payment
|
| Ascend Therapeutics US | Estrogel | $18 | 1 payment
|
2023: $631
| Abbvie | Ubrelvy | $293 | 17 payments
|
| Axsome Therapeutics | Sunosi | $102 | 4 payments
|
| Pfizer | Nurtec Odt | $80 | 4 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $63 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $47 | 2 payments
|
| Tolmar | Fensolvi | $28 | 1 payment
|
| Amgen | Otezla | $18 | 1 payment
|
2022: $2,235
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $1,967 | 11 payments
|
| Abbvie | Ubrelvy | $207 | 12 payments
|
| TOLMAR Pharmaceuticals | Fensolvi | $24 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $21 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $16 | 1 payment
|
2021: $543
| AbbVie | Ubrelvy | $258 | 14 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $145 | 8 payments
|
| Eisai | Dayvigo | $72 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $38 | 2 payments
|
| Acerus Pharmaceuticals | Natesto | $17 | 1 payment
|
| ASCEND Therapeutics US | Estrogel | $13 | 1 payment
|
2020: $179
| Eisai | Dayvigo | $80 | 4 payments
|
| Amgen | Aimovig | $29 | 1 payment
|
| Allergan | Ubrelvy | $21 | 1 payment
|
| AbbVie | Creon | $21 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $12 | 1 payment
|
2019: $243
| AbbVie | Creon | $87 | 4 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $86 | 4 payments
|
| Pfizer | Toviaz | $39 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $18 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
Professional record
- NPI
- 1285625236
- Licence
- CA G72042California G72042: Current · expires 2027-03-31
- Trained
- Michigan State University College of Human Medicine, 1988
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 605 Cowper St, Palo Alto, CA, 94301
- NPI first listed
- 2005-10-31
- NPI last updated
- 2009-12-10
This is when the NPI record was last certified, not a medical board exam.